FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

The Food and Drug Administration (FDA) authorized Novavax’s COVID vaccine for adults on Wednesday, offering a protein-based alternative to mRNA shots from other pharmaceutical companies.

The newly authorized vaccine is scheduled in two doses separated by 21 days.

 

FDA Authorizes Novavax COVID Vaccine

FDA Authorizes Novavax COVID Vaccine

U.S. and Iran Resume High-Stakes Nuclear Talks in Oman Amid Rising Regional Tensions

The United States and Iran resumed nuclear negotiations…
FDA Authorizes Novavax COVID Vaccine
FDA Authorizes Novavax COVID Vaccine

Could Iran Play a Role in a Future Temple Agreement?

An unexpected voice from inside the Iranian opposition is raising…